LMNA -Related Dilated Cardiomyopathy: Single-Cell Transcriptomics during Patient-derived iPSC Differentiation Support Cell type and Lineage-specific Dysregulation of Gene Expression and Development for Cardiomyocytes and Epicardium-Derived Cells with Lamin A/C Haploinsufficiency

Michael V. Zaragoza, Thuy-Anh Bui, Halida P. Widyastuti, Mehrsa Mehrabi, Zixuan Cang, Yutong Sha, Anna Grosberg, Qing NiebioRxiv 2024 · DOI

TL;DR

This study uses single-cell RNA sequencing on patient-derived induced pluripotent stem cells (iPSCs) to uncover how a specific mutation in the LMNA gene leads to dilated cardiomyopathy. They found that this mutation causes widespread dysregulation of gene expression and developmental pathways in various cell types, particularly cardiomyocytes and epicardium-derived cells, supporting a "gene expression" hypothesis for the disease mechanism.

What Problem Does This Paper Address?

Dilated cardiomyopathy (DCM) linked to LMNA gene mutations is a serious, inherited heart condition that can lead to heart failure or sudden death. While we know LMNA mutations affect nuclear integrity and gene regulation, the precise molecular mechanisms driving DCM remain unclear. Current treatments are limited, highlighting the need to understand how these mutations disrupt heart development and function at a cellular level. This paper aims to shed light on these mechanisms by using a sophisticated iPSC model to study the effects of a specific LMNA mutation on the development of heart cells.

Methods

The core of this study is a comprehensive single-cell RNA sequencing (scRNA-seq) approach. They used patient-derived iPSCs and differentiated them into various cardiac cell types over several time points. The scRNA-seq data was processed through a rigorous bioinformatics pipeline involving:

  • Data Processing: Initial read mapping and quality control (QC) using Cell Ranger, followed by background RNA removal (SoupX), low-quality cell filtering (Seurat), and doublet removal (DoubletFinder).
  • Data Analysis: Unsupervised clustering, cell annotation using known marker genes, and subclustering to identify cell types and subtypes.
  • Data Combining & Comparative Analyses: Merging and integrating data from patient and control samples to perform differential gene expression (DEG) analysis and pathway enrichment analysis (ORA and GSEA).
  • Trajectory Inference: Using Slingshot and TradeSeq to understand cell lineage progression and identify lineage-specific DEGs.
  • Western Blotting: Used to confirm protein level changes for Lamin A/C.

Datasets

The study utilized data from:

  • Patient-derived iPSC lines: One LMNA mutant line from an affected female.
  • Control iPSC lines: Two non-mutant lines from her unaffected sister, plus an additional unrelated control line.
  • Time points: Samples were collected at seven time points during iPSC differentiation (Day 0, 2, 4, 9, 16, 19, and 30).
  • Total cells: 125,554 cells were collected, with 110,521 (88%) high-quality cells used for analysis.

Key Insights and Ideas

  • Complexity of iPSC Differentiation: The study highlights the intricate heterogeneity of cell types, subtypes, and lineages that emerge during iPSC differentiation into cardiomyocytes, even in healthy controls.
  • "Gene Expression" Hypothesis: The findings strongly support the "gene expression" hypothesis for LMNA-related DCM, suggesting that the mutation primarily disrupts gene regulation and epigenomic programs rather than solely mechanical stress on the nucleus.
  • Cell Type and Lineage Specificity: The LMNA mutation's impact is not uniform; it specifically dysregulates gene expression and developmental pathways in certain cell types (like cardiomyocytes and epicardium-derived cells) and along specific developmental lineages.
  • X-linked and Imprinted Gene Dysregulation: Beyond LMNA itself, the study identified significant dysregulation of X-linked genes (including XIST) and imprinted genes, suggesting broader epigenetic reprogramming issues.

Key Results

  • 10 Main Cell Types Identified: The analysis revealed ten distinct cell types during iPSC differentiation, including Pluripotent cells (PP), Mesendoderm (ME), Cardiogenic Mesoderm (CMESO), Endoderm (ENDO), Ectoderm (ECTO), Endothelium (ENDOTH), Cardiac Progenitors (CP), Cardiomyocytes (CM), Epicardium-Derived Cells (EPDC), and Unknown (UNK).
  • LMNA Underexpression: LMNA was consistently underexpressed in patient-derived cells, particularly in CM and EPDC at later time points.
  • XIST and Imprinted Gene Alterations: XIST showed reduced expression in patient cells, and several imprinted genes (SNRPN, PWAR6, NDN, PEG10, MEG3, MEG8) also exhibited differential expression.
  • Pathway Dysregulation: Enriched pathways indicated dysregulation in cell signaling (TGF Beta, mTORC1), cardiogenesis, EMT, metabolism, and epigenetic regulation in patient cells compared to controls.
  • Protein Level Reduction: Western blot analysis confirmed decreased Lamin A/C protein levels in patient-derived cells, although statistical significance varied between pairwise comparisons.

Limitations and Future Work

The authors acknowledge the inherent challenges in interpreting scRNA-seq data due to biological and technical variability. Factors like differences between iPSC lines and clones, and the susceptibility of iPSCs to epigenomic aberrations, can influence gene expression and differentiation.

Future work should focus on:

  • Reducing Confounding Factors: Conducting larger scRNA-seq studies with more biological replicates and isogenic control iPSC lines (created via genome editing) to better isolate the effects of the LMNA mutation.
  • Addressing Epigenomic Aberrations: Investigating and mitigating potential epigenomic changes in iPSCs, such as altered XIST expression, XCI erosion, and DNA methylation changes.
  • Investigating Molecular Memory: Exploring methods to "wipe away" fibroblast epigenomic memory in iPSCs to create cells in a more naive pluripotent state, resembling human ESCs.
  • Validating Mechanisms: Further testing the "gene expression" hypothesis for LMNA-related DCM using these improved models.

Summary updated

Abstract

ABSTRACT LMNA -Related Dilated Cardiomyopathy (DCM) is an autosomal-dominant genetic condition with cardiomyocyte and conduction system dysfunction often resulting in heart failure or sudden death. The condition is caused by mutation in the Lamin A/C ( LMNA ) gene encoding Type-A nuclear lamin proteins involved in nuclear integrity, epigenetic regulation of gene expression, and differentiation. Molecular mechanisms of disease are not completely understood, and there are no definitive treatments to reverse progression or prevent mortality. We investigated possible mechanisms of LMNA -Related DCM using induced pluripotent stem cells derived from a family with a heterozygous LMNA c.357-2A>G splice-site mutation. We differentiated one LMNA mutant iPSC line derived from an affected female (Patient) and two non-mutant iPSC lines derived from her unaffected sister (Control) and conducted single-cell RNA sequencing for 12 samples (4 Patient and 8 Control) across seven time points: Day 0, 2, 4, 9, 16, 19, and 30. Our bioinformatics workflow identified 125,554 cells in raw data and 110,521 (88%) high-quality cells in sequentially processed data. Unsupervised clustering, cell annotation, and trajectory inference found complex heterogeneity: ten main cell types; many possible subtypes; and lineage bifurcation for Cardiac Progenitors to Cardiomyocytes (CM) and Epicardium-Derived Cells (EPDC). Data integration and comparative analyses of Patient and Control cells found cell type and lineage differentially expressed genes (DEG) with enrichment to support pathway dysregulation. Top DEG and enriched pathways included: 10 ZNF genes and RNA polymerase II transcription in Pluripotent cells (PP); BMP4 and TGF Beta/BMP signaling, sarcomere gene subsets and cardiogenesis, CDH2 and EMT in CM; LMNA and epigenetic regulation and DDIT4 and mTORC1 signaling in EPDC. Top DEG also included: XIST and other X-linked genes, six imprinted genes: SNRPN , PWAR6 , NDN , PEG10 , MEG3 , MEG8 , and enriched gene sets in metabolism, proliferation, and homeostasis. We confirmed Lamin A/C haploinsufficiency by allelic expression and Western blot. Our complex Patient-derived iPSC model for Lamin A/C haploinsufficiency in PP, CM, and EPDC provided support for dysregulation of genes and pathways, many previously associated with Lamin A/C defects, such as epigenetic gene expression, signaling, and differentiation. Our findings support disruption of epigenomic developmental programs as proposed in other LMNA disease models. We recognized other factors influencing epigenetics and differentiation; thus, our approach needs improvement to further investigate this mechanism in an iPSC-derived model.
BibTeX
@misc{zaragoza2024i,
  author = {Michael V. Zaragoza and Thuy-Anh Bui and Halida P. Widyastuti and Mehrsa Mehrabi and Zixuan Cang and Yutong Sha and Anna Grosberg and Qing Nie},
  title = {{<i>LMNA</i> -Related Dilated Cardiomyopathy: Single-Cell Transcriptomics during Patient-derived iPSC Differentiation Support Cell type and Lineage-specific Dysregulation of Gene Expression and Development for Cardiomyocytes and Epicardium-Derived Cells with Lamin A/C Haploinsufficiency}},
  year = {2024},
  doi = {10.1101/2024.06.12.598335},
  howpublished = {bioRxiv},
}
Figure